EXPEDIA GROUP INC (EXPE) Stock Fundamental Analysis

USA Nasdaq NASDAQ:EXPE • US30212P3038

236.85 USD
+5.55 (+2.4%)
At close: Feb 6, 2026
237 USD
+0.15 (+0.06%)
After Hours: 2/6/2026, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPE. EXPE was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. EXPE has an excellent profitability rating, but there are some minor concerns on its financial health. EXPE may be a bit undervalued, certainly considering the very reasonable score on growth This makes EXPE very considerable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • EXPE had positive earnings in the past year.
  • EXPE had a positive operating cash flow in the past year.
  • In multiple years EXPE reported negative net income over the last 5 years.
  • Of the past 5 years EXPE 4 years had a positive operating cash flow.
EXPE Yearly Net Income VS EBIT VS OCF VS FCFEXPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.53%, EXPE is in the better half of the industry, outperforming 71.97% of the companies in the same industry.
  • The Return On Equity of EXPE (103.81%) is better than 96.21% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 18.46%, EXPE belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
  • EXPE had an Average Return On Invested Capital over the past 3 years of 10.99%. This is in line with the industry average of 10.42%.
  • The 3 year average ROIC (10.99%) for EXPE is below the current ROIC(18.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.53%
ROE 103.81%
ROIC 18.46%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
EXPE Yearly ROA, ROE, ROICEXPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • With a decent Profit Margin value of 9.66%, EXPE is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • EXPE's Profit Margin has improved in the last couple of years.
  • The Operating Margin of EXPE (13.72%) is better than 65.91% of its industry peers.
  • In the last couple of years the Operating Margin of EXPE has grown nicely.
  • EXPE's Gross Margin of 89.94% is amongst the best of the industry. EXPE outperforms 98.48% of its industry peers.
  • EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.72%
PM (TTM) 9.66%
GM 89.94%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
EXPE Yearly Profit, Operating, Gross MarginsEXPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

5

2. Health

2.1 Basic Checks

  • EXPE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, EXPE has less shares outstanding
  • The number of shares outstanding for EXPE has been reduced compared to 5 years ago.
  • EXPE has a better debt/assets ratio than last year.
EXPE Yearly Shares OutstandingEXPE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPE Yearly Total Debt VS Total AssetsEXPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 1.44, we must say that EXPE is in the distress zone and has some risk of bankruptcy.
  • EXPE has a Altman-Z score (1.44) which is comparable to the rest of the industry.
  • EXPE has a debt to FCF ratio of 2.07. This is a good value and a sign of high solvency as EXPE would need 2.07 years to pay back of all of its debts.
  • The Debt to FCF ratio of EXPE (2.07) is better than 85.61% of its industry peers.
  • A Debt/Equity ratio of 3.34 is on the high side and indicates that EXPE has dependencies on debt financing.
  • EXPE has a Debt to Equity ratio (3.34) which is in line with its industry peers.
  • Even though the debt/equity ratio score it not favorable for EXPE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 3.34
Debt/FCF 2.07
Altman-Z 1.44
ROIC/WACC2.38
WACC7.77%
EXPE Yearly LT Debt VS Equity VS FCFEXPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

  • EXPE has a Current Ratio of 0.74. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EXPE has a worse Current ratio (0.74) than 62.12% of its industry peers.
  • A Quick Ratio of 0.74 indicates that EXPE may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.74, EXPE perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
EXPE Yearly Current Assets VS Current LiabilitesEXPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.19% over the past year.
  • EXPE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.87% yearly.
  • Looking at the last year, EXPE shows a small growth in Revenue. The Revenue has grown by 7.29% in the last year.
  • The Revenue has been growing slightly by 2.56% on average over the past years.
EPS 1Y (TTM)26.19%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%23.49%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%8.67%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.91% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.82% on average over the next years.
EPS Next Y24.89%
EPS Next 2Y23.02%
EPS Next 3Y21.85%
EPS Next 5Y17.91%
Revenue Next Year7.5%
Revenue Next 2Y7.4%
Revenue Next 3Y7.31%
Revenue Next 5Y6.82%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EXPE Yearly Revenue VS EstimatesEXPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
EXPE Yearly EPS VS EstimatesEXPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

8

4. Valuation

4.1 Price/Earnings Ratio

  • EXPE is valuated correctly with a Price/Earnings ratio of 16.22.
  • Compared to the rest of the industry, the Price/Earnings ratio of EXPE indicates a somewhat cheap valuation: EXPE is cheaper than 79.55% of the companies listed in the same industry.
  • EXPE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • EXPE is valuated correctly with a Price/Forward Earnings ratio of 12.79.
  • EXPE's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXPE is cheaper than 82.58% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.77. EXPE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 16.22
Fwd PE 12.79
EXPE Price Earnings VS Forward Price EarningsEXPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • EXPE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EXPE is cheaper than 62.88% of the companies in the same industry.
  • 93.18% of the companies in the same industry are more expensive than EXPE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.68
EV/EBITDA 10.08
EXPE Per share dataEXPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EXPE has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXPE's earnings are expected to grow with 21.85% in the coming years.
PEG (NY)0.65
PEG (5Y)1.09
EPS Next 2Y23.02%
EPS Next 3Y21.85%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.69%, EXPE is not a good candidate for dividend investing.
  • EXPE's Dividend Yield is a higher than the industry average which is at 1.26.
  • Compared to an average S&P500 Dividend Yield of 1.81, EXPE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

  • EXPE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXPE Yearly Dividends per shareEXPE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y23.02%
EPS Next 3Y21.85%
EXPE Yearly Income VS Free CF VS DividendEXPE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

NASDAQ:EXPE (2/6/2026, 8:00:01 PM)

After market: 237 +0.15 (+0.06%)

236.85

+5.55 (+2.4%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06
Earnings (Next)02-12
Inst Owners103.43%
Inst Owner Change-5.1%
Ins Owners0.52%
Ins Owner Change0.13%
Market Cap29.02B
Revenue(TTM)14.37B
Net Income(TTM)1.39B
Analysts72.73
Price Target291.61 (23.12%)
Short Float %5.29%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.37%
Min EPS beat(2)1.46%
Max EPS beat(2)7.27%
EPS beat(4)4
Avg EPS beat(4)11.2%
Min EPS beat(4)1.46%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)30.46%
EPS beat(12)9
Avg EPS beat(12)-11.57%
EPS beat(16)12
Avg EPS beat(16)-2.63%
Revenue beat(2)2
Avg Revenue beat(2)0.58%
Min Revenue beat(2)0.11%
Max Revenue beat(2)1.05%
Revenue beat(4)3
Avg Revenue beat(4)0%
Min Revenue beat(4)-2.83%
Max Revenue beat(4)1.66%
Revenue beat(8)4
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-0.96%
PT rev (1m)5.49%
PT rev (3m)26.79%
EPS NQ rev (1m)2.94%
EPS NQ rev (3m)23.33%
EPS NY rev (1m)0.37%
EPS NY rev (3m)5.6%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)3.02%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE 16.22
Fwd PE 12.79
P/S 2.02
P/FCF 9.68
P/OCF 7.69
P/B 21.71
P/tB N/A
EV/EBITDA 10.08
EPS(TTM)14.6
EY6.16%
EPS(NY)18.53
Fwd EY7.82%
FCF(TTM)24.47
FCFY10.33%
OCF(TTM)30.8
OCFY13%
SpS117.28
BVpS10.91
TBVpS-51.69
PEG (NY)0.65
PEG (5Y)1.09
Graham Number59.87
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 103.81%
ROCE 25.12%
ROIC 18.46%
ROICexc 86.41%
ROICexgc N/A
OM 13.72%
PM (TTM) 9.66%
GM 89.94%
FCFM 20.86%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score9
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 3.34
Debt/FCF 2.07
Debt/EBITDA 1.57
Cap/Depr 88.28%
Cap/Sales 5.4%
Interest Coverage 8.04
Cash Conversion 132.42%
Profit Quality 215.99%
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z 1.44
F-Score9
WACC7.77%
ROIC/WACC2.38
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.19%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%23.49%
EPS Next Y24.89%
EPS Next 2Y23.02%
EPS Next 3Y21.85%
EPS Next 5Y17.91%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%8.67%
Revenue Next Year7.5%
Revenue Next 2Y7.4%
Revenue Next 3Y7.31%
Revenue Next 5Y6.82%
EBIT growth 1Y28.99%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year151.63%
EBIT Next 3Y45.49%
EBIT Next 5Y29.72%
FCF growth 1Y57.79%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y37.44%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%

EXPEDIA GROUP INC / EXPE FAQ

Can you provide the ChartMill fundamental rating for EXPEDIA GROUP INC?

ChartMill assigns a fundamental rating of 6 / 10 to EXPE.


What is the valuation status of EXPEDIA GROUP INC (EXPE) stock?

ChartMill assigns a valuation rating of 8 / 10 to EXPEDIA GROUP INC (EXPE). This can be considered as Undervalued.


Can you provide the profitability details for EXPEDIA GROUP INC?

EXPEDIA GROUP INC (EXPE) has a profitability rating of 8 / 10.


What is the financial health of EXPEDIA GROUP INC (EXPE) stock?

The financial health rating of EXPEDIA GROUP INC (EXPE) is 5 / 10.